Gastroenterology
The findings of a recent study may help researchers to characterize the composition of the human gut microbiota in health and disease.
The findings of a recent study suggest that FMT is an effective strategy to mitigate the intestinal side effects of cancer immunotherapy.
Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.
A recent review highlights that changes in fear-related mental health conditions are observed when the gut microbiota is altered or removed.
Osnat Tirosh, Head of Microbiome Research & Innovation at Biomica, talks about the validation of the mechanism of action of BMC333 consortia through pre-clinical studies in IBD models.
IgA can modulate the exposure and immune response to commensal microbes, and its levels determine the severity of immune dysregulation and clinical symptoms in people with IgA deficiency.
The findings of a new study suggest that the new nanomedicine approach can improve the delivery of TNF-α-siRNA in people with IBD.
A recent study poses the basis for the use of microbiome profile in AF risk prediction.
The findings of a recent study suggest that the gut microbiota contributes to improve metabolic health after gastric bypass surgery.
Depressed BD patients present significant alterations in the taxonomic compositions of their gut microbiota, and this may be related to inflammatory pathways and depression severity.
